This website does not support Internet Explorer. Please, switch to Edge, Chrome, or Firefox browser to view this page.

Learn about IE support
O9 whitepaper biopharma mockup
White paper

Addressing biopharma supply chain complexity to create a strategic advantage

  • Learn how biopharma companies can address the increasing complexity in their supply chains.

I agree to the privacy policy.

I agree to the privacy policy.

I agree to the privacy policy.

I agree to the privacy policy.

Kobayashi Pharma
Intuitive Surgical
Google
Walmart
Samsung
PepsiCo
Caterpillar
Pirelli & C. SpA
Anheuser-Busch InBev
Kobayashi Pharma
Intuitive Surgical
Google
Walmart
Samsung
PepsiCo
Caterpillar
Pirelli & C. SpA
Anheuser-Busch InBev
Trusted by leaders across industry verticals

What you will learn

Solve biopharma issues

The current state of the biopharma industry, including the latest innovations driving supply chain complexity.

Manage complexity

The five key drivers and challenges driving complexity in the biopharma supply chain and why should the industry focus on managing them.

Effective strategy

The key value drivers required to effectively address biopharma supply chain complexity to create a strategic advantage.

Patient-centric therapies through innovation

Patient-centric therapies through innovation

The biopharmaceutical industry is evolving toward highly personalized patient-centric therapies. While these next-generation treatments have brought newfound hope to patients, they add complexity to one of the most intricate and high stakes supply chains. Each product can have hundreds of variants depending on the process complexity, country, quality standards, and regulatory approvals across the end-to-end product flow.

Pharmaceutical manufacturing

Out with the Excel and gain greater visibility

Out with the Excel and gain greater visibility

Additionally, a fragmented IT landscape, a reliance on manual spreadsheet-based planning processes, and a lack of visibility and collaboration with external partners greatly hinder biopharma companies’ supply chain planning and decision-making abilities.

Learn about the factors driving biopharmaceutical supply chain complexity and how the industry can address them to create a strategic advantage.

Person working in a laboratory
Ibm whitepaper 2 1

Addressing biopharma supply chain complexity to create a strategic advantage

Learn how biopharma companies can address the increasing complexity in their supply chains.

I agree to the privacy policy.

I agree to the privacy policy.

Resources

View our related articles, white papers & use cases

White Paper50 min

Quality Brand Growth in the Age of Disruption

O9 whitepaper ipa mockup
article4 min

Balancing Sustainability and Profitability in Metal Industry

by o9 Solutions
Supply chain metals industry blog
article3 min

Transforming your commercial investment decisions and processes to withstand market disruptions

by o9 Solutions
Headerimage poi
article5 min

What makes a best-in-class sustainable company?

by Christina Andreou
Aurora borealis
Analyst Report65 min

2022 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions

Gartner us2022 linkedin
article2 min

What is the value of omnichannel retailing?

by Vikas Goel
a person looking at different retailing channels when shopping online
o9

The Digital Brain
of Your Enterprise

© – o9 Solutions, Inc.
Privacy policy
Cookie Policy
Privacy policy